PORTRAIT Trademark
Trademark Overview
On Thursday, February 11, 2021, a trademark application was filed for PORTRAIT with the United States Patent and Trademark Office. The USPTO has given the PORTRAIT trademark a serial number of 90524707. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, November 21, 2024. This trademark is owned by BostonGene Corporation. The PORTRAIT trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable software for displaying, recording, and analyzing medical data and medical images
Providing collected and analyzed medical information in the field of genetics, epigenetics, and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing online computer databases of genomic sequences for health care and medical purposes, namely, for tracking, matching, searching, testing, aggregating, and evaluating health status, and diagnosing diseases and gene mutations; providing an online internet website portal featuring medical information, namely, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes
Providing online, non-downloadable software for genetic and epigenetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online, non-downloadable software used for the sequencing and analyses of genomic, epigenomic, proteomic, and transcriptomic data; providing online computer databases featuring scientific research information in the nature of genomic sequences for use in scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, epigenomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for patient treatment protocols and for re...
General Information
Serial Number | 90524707 |
Word Mark | PORTRAIT |
Filing Date | Thursday, February 11, 2021 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Thursday, November 21, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Downloadable software for displaying, recording, and analyzing medical data and medical images |
Goods and Services | Providing collected and analyzed medical information in the field of genetics, epigenetics, and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing online computer databases of genomic sequences for health care and medical purposes, namely, for tracking, matching, searching, testing, aggregating, and evaluating health status, and diagnosing diseases and gene mutations; providing an online internet website portal featuring medical information, namely, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes |
Goods and Services | Providing online, non-downloadable software for genetic and epigenetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online, non-downloadable software used for the sequencing and analyses of genomic, epigenomic, proteomic, and transcriptomic data; providing online computer databases featuring scientific research information in the nature of genomic sequences for use in scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, epigenomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, epigenomics, proteomics, transcriptomics, and biochemistry; providing an online internet website portal featuring medical, genetic, epigenetic, genomic, epigenomic, proteomic, and transcriptomic research information and data for scientific, laboratory, and medical research and development purposes; providing online, non-downloadable software for displaying, recording, and analyzing medical data and medical images |
Classification Information
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 7, 2022 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, January 7, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, May 15, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | BostonGene Corporation |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Waltham, MA 02453 |
Trademark Events
Event Date | Event Description |
Saturday, May 15, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, September 8, 2021 | ASSIGNED TO EXAMINER |
Thursday, October 14, 2021 | NON-FINAL ACTION WRITTEN |
Thursday, October 14, 2021 | NON-FINAL ACTION E-MAILED |
Thursday, October 14, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, January 7, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, January 7, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, January 7, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, January 7, 2022 | SUSPENSION LETTER WRITTEN |
Friday, January 7, 2022 | CORRESPONDENCE E-MAILED |
Thursday, July 7, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Thursday, January 5, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Saturday, July 8, 2023 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Friday, January 5, 2024 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
Thursday, November 21, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, November 21, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, November 21, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |